Funded Projects

The molecular mechanism of SNORD116 action (year 2)

Funding Summary

 Dr. Stamm has been studying the normal function of the SNORD116 genes in PWS. In year 1, he has determined that SNORD116 plays a role in RNA stability, which may be important in controlling circadian rhythm and hormone release. In year 2 his group will examine how SNORD116 binds to these RNAs and controls their stability. 

Lay Abstract

SNORD116 is a C/D box small nucleolar RNA that is critical for the etiology of PWS, as microdeletions encompassing only SNORD116 cause a PWS-like phenotype. The molecular functions of SNORD116 have been elusive, preventing therapy design. We showed that SNORD116 is not a typical snoRNA, as it associates with different proteins and has a different cellular localization than 'normal C/D box snoRNAs'. We found that SNORD116's main function is to regulate the stability of mRNAs, generally decresing the stability through direct binding to control regions.

Most of SNORD116's targets are genes that are rapidly induced after neuronal activation and SNORD116's physiologial function could be to accelerate the degradation of these RNAs. Thus SNORD116 ensures that after stimulation mRNAs are rapidly degraded, which generates narrow 'spikes' of increased/decreased mRNA concentration that are necessary for circadian rhythm (day and night cycles) and pulsed hormone release.

We will measure the half-life (i.e. stability) of all mRNAs in PWS and control cells and determine how SNORD116 binds to these mRNAs, which will allow us to test small molecules for their ability to replace SNORD116.

Funded Year:

2018

Awarded to:

Stefan Stamm, Ph.D.

Amount:

$86,400

Institution:

University of Kentucky

Researcher:

stamm